沃尔格林 (Walgreens) 记录第二季度 VillageMD 诊所价值下降导致 $5.8B 减值费用。 Walgreens records $5.8B impairment charge for VillageMD clinic value drop in Q2.
沃尔格林 (Walgreens) 报告称，由于 VillageMD 诊所价值下降，第二季度亏损 60 亿美元。 Walgreens reports $6B loss in Q2 due to VillageMD clinic value drop. 除去这项费用，该公司的业绩超出了华尔街的预期。 Excluding this charge, the company's results beat Wall Street expectations. 沃尔格林 (Walgreens) 于 2018 年斥资超过 50 亿美元收购了 VillageMD 的多数股权，打算扩大其医疗保健服务。 Walgreens spent over $5B to acquire a majority stake in VillageMD in 2018, intending to expand its healthcare services. 该公司在最近一个季度为 VillageMD 记录了 5.8B 美元的税后减值费用，因为它调整了资产价值，反映了医疗保健业务的困境。 The company recorded a $5.8B after-tax impairment charge for VillageMD in the most recent quarter as it adjusted the asset's value, reflecting the struggling healthcare business.